Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338).

已完结 20 由 Luke 发布于 2025/8/4 14:45:20

DOI:10.1007/s40262-022-01189-0
作者：Olivier Petricoul,?Arman Nazarian,?Uwe Schuehly,?Ursula Schramm,?Olivier J David,?Didier Laurent,?Jens Praestgaard,?Ronenn Roubenoff,?Dimitris A Papanicolaou,?Daniel Rooks
文献类型：期刊论文
补充材料：只需要正文

Springer

Abstract：Background: Bimagrumab is a human monoclonal antibody binding to the activin type II receptor with therapeutic potential in conditions of muscle wasting and obesity. This phase I study evalu

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileyFunctional Group Engineering Stabilizing Precursor Solution and Passivating Defects for Operationally Stable and Highly Reproducible Inverted Perovskite Solar Cells